Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.58%177.330.4%$130.43m
PRGOPerrigo Co. Plc
0.44%72.896.8%$98.50m
MNKMallinckrodt Plc
0.39%29.7921.1%$71.88m
JAZZJazz Pharmaceuticals Plc
0.46%161.752.2%$70.15m
ENDPEndo International Plc
0.88%15.998.9%$60.18m
PTLAPortola Pharmaceuticals, Inc.
-0.32%28.317.7%$40.42m
UTHRUnited Therapeutics Corporation
-0.20%125.6914.4%$39.09m
SAGESAGE Therapeutics, Inc.
2.13%148.229.6%$37.60m
CTLTCatalent Inc
0.70%42.872.4%$36.75m
ICPTIntercept Pharmaceuticals, Inc.
0.72%119.6318.7%$31.34m
GWPHGW Pharmaceuticals PLC Sponsored ADR
3.94%146.496.8%$30.41m
ZGNXZogenix, Inc.
1.13%49.0511.9%$30.20m
SUPNSupernus Pharmaceuticals, Inc.
4.46%48.056.2%$28.39m
MDCOMedicines Company
1.79%34.1621.8%$25.46m
ICLRICON Plc
0.71%146.304.2%$24.00m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.